Evidence map›Paper›PMID 32118353›Full record

ArticleMolecular oncology2020

Norepinephrine-CREB1-miR-373 axis promotes progression of colon cancer.

Jia Han, Qiuyu Jiang, Ruili Ma, Huahua Zhang, Dongdong Tong, Kaijie Tang, Xiaofei Wang, Lei Ni, Jiyu Miao, Baojun Duan and 7 more

Open access · goldAbstract read
In one paragraph

Article in Molecular oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Jia HanDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Qiuyu JiangDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Ruili MaSchool of Basic Medical Science, Xi'an Medical University, China.
Huahua ZhangMedical College, Yan'an University, China.
Dongdong TongDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Kaijie TangDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Xiaofei WangDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Lei NiDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Jiyu MiaoDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Baojun DuanDepartment of Medical Oncology, The Third Affiliated Hospital to Xi'an Jiaotong University, China.
Yang YangDepartment of Health Toxicology and Hygiene Inspection, School of Public Health, Xi'an Jiaotong University Health Science Center, China.
Yanke ChenDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Fei WuDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Jiming HanMedical College, Yan'an University, China.
Mengchang WangDepartment of Hematology, The First Hospital Affiliated to Xi'an Jiaotong University, China.
Ni HouDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.ORCID 0000-0002-4721-6525
Chen HuangDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, China.
Xi'an Jiaotong University · CNYan'an University · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNMinistry of Education of the People's Republic of China · CNShaanxi Provincial People's Hospital · CNXi'an Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adrenergic system contributes to the stress-induced onset and progression of cancer. Adrenergic fibers are the primary source of norepinephrine (NE). The underlying mechanisms involved in NE-induced colon cancer remain to be understood. In this study, we describe the function and regulatory network of NE in the progression of colon cancer. We demonstrate that NE-induced phosphorylation of cAMP response element-binding protein 1 (CREB1) promotes proliferation, migration, and invasion of human colon cancer cells. The downstream effector of NE, CREB1, bound to the promoter of miR-373 and transcriptionally activated its expression. miR-373 expression was shown to be necessary for NE-induced cell proliferation, invasion, and tumor growth. We confirmed that proliferation and invasion of colon cancer cells are regulated in vitro and in vivo by miR-373 through targeting of the tumor suppressors TIMP2 and APC. Our data suggest that NE promotes colon cancer cell proliferation and metastasis by activating the CREB1-miR-373 axis. The study of this novel signaling axis may provide mechanistic insights into the neural regulation of colon cancer and help in the design of future clinical studies on stress biology in colorectal cancer.

Indexed as

Adenomatous Polyposis Coli ProteinAnimalsCarcinogenesisCell Line, TumorCell MovementCell ProliferationColonic NeoplasmsCyclic AMP Response Element-Binding ProteinGene Expression Regulation, NeoplasticHumansMiceMice, NudeMicroRNAsNeoplasm InvasivenessNorepinephrineTissue Inhibitor of Metalloproteinase-2Adenomatous Polyposis Coli ProteinAPC protein, humanCREB1 protein, humanCyclic AMP Response Element-Binding ProteinMicroRNAsMIRN373 microRNA, humanNorepinephrineTIMP2 protein, humanTissue Inhibitor of Metalloproteinase-2colorectal cancerCREB1miR-373NETIMP2

Identifiers

PMID32118353
PMCPMC7191185
OpenAlexW3010593785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.